Stocks Comparison
Mettler Toledo International Inc/ vs 10x Genomics: revenue, profit, margins and growth compared
Mettler Toledo International Inc/ brought in $4B of revenue in fiscal 2025, 10x Genomics $642.8M in fiscal 2025. Revenue changed by +4.0% at Mettler Toledo International Inc/ and +5.2% at 10x Genomics on the year before, so 10x Genomics grew faster. Mettler Toledo International Inc/ kept 21.6% of its revenue as net profit, 10x Genomics -6.8%. Free cash flow was $848.6M at Mettler Toledo International Inc/ and $130.1M at 10x Genomics.
Side by side, latest fiscal year
| MTD | TXG | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $4B | $642.8M |
| Revenue growth | +4.0% | +5.2% |
| Net income | $869.2M | -$43.5M |
| Net margin | 21.6% | -6.8% |
| Free cash flow | $848.6M | $130.1M |
| Free cash flow margin | 21.1% | 20.2% |
| Earnings per share (diluted) | $42.05 | -$0.35 |
| Cash | $66.9M | $474M |
| Debt | $2.1B | n/a |
| Price to earnings | 36.0 | n/a |
| Market value | $30.3B | $11.2B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #140 of 451 · Industrials | #299 of 451 · Industrials |
Over the years
Questions about Mettler Toledo International Inc/ and 10x Genomics
Which is bigger by revenue, Mettler Toledo International Inc/ or 10x Genomics?
Mettler Toledo International Inc/ is bigger by revenue: $4B in fiscal 2025, against $642.8M for 10x Genomics in fiscal 2025.
Which keeps more of its revenue as profit, Mettler Toledo International Inc/ or 10x Genomics?
Mettler Toledo International Inc/ had a net margin of 21.6% in fiscal 2025; 10x Genomics had -6.8% in fiscal 2025.
Which grew revenue faster, Mettler Toledo International Inc/ or 10x Genomics?
In their latest fiscal years revenue changed by +4.0% at Mettler Toledo International Inc/ and +5.2% at 10x Genomics.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.